Mylan Investors

As one of the world’s leading generics and specialty pharmaceutical companies, our products reach approximately 165 countries and territories. Our leading position in key global markets is based on a broad product portfolio, robust pipeline, more than 35,000 workforce, wide range of dosage forms and delivery systems, large manufacturing capacity and dedication to quality and service.

2016.07.29, 4:00 PM ET

MYL Last Trade

46.79

Change

+0.07

Daily High

46.94

Daily Low

46.11

Daily Volume

2,658,918




Download 2016 AGM
Notice, Proxy Statement, 
and Proxy Card

May 25, 2016

Supplemental Proxy
Material

June 3, 2016
 


Download Latest
10-K/A

April 29, 2016
 
Download Latest Dutch
Board Report and Dutch
Annual Accounts

April 27, 2016
 

Mylan will provide shareholders, upon request, a hard copy of its latest 10-K free of charge.  



Get the latest from Mylan
Sign up for email alerts




Upcoming Events

Event Default

Second Quarter 2016 Financial Results

Aug. 09, 2016 | 4:30 PM EDT

Listen to Webcast

Past Events

Event Default

Goldman Sachs 37th Annual Global Healthcare Conference

Jun. 7, 2016 | 5:40 PM EDT





Leadership

Meet our passionate global leaders.